BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 28714532)

  • 41. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.
    Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
    Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytological Sub-Classification of Atypia of Undetermined Significance May Predict Malignancy Risk in Thyroid Nodules.
    Elomami A; Elhag SA; Alseddeeqi E
    Acta Cytol; 2021; 65(3):205-212. PubMed ID: 33524971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An institutional experience: A retrospective analysis of the effect of transitioning from follicular lesion of undetermined significance to atypia of undetermined significance with subclassified atypia on interobserver concordance, rates of neoplasia, and rates of malignancy.
    Kroll-Wheeler L; Cantley R; Pang JC; Soles BS; Smola B; Jing X; Lew M
    Diagn Cytopathol; 2021 Jan; 49(1):31-38. PubMed ID: 32936526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The predictive value of hematologic parameters in the risk of thyroid malignancy in cases with atypia/follicular lesion of undetermined significance.
    Bostan H; Sencar ME; Calapkulu M; Hepsen S; Akhanli P; Duger H; Ucan B; Kizilgul M; Ozturk Unsal I; Ozbek M; Cakal E
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4077-4084. PubMed ID: 35006341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of ultrasound findings in the management of thyroid nodules with atypia or follicular lesions of undetermined significance.
    Yoo WS; Choi HS; Cho SW; Moon JH; Kim KW; Park HJ; Park SY; Choi SI; Choi SH; Lim S; Yi KH; Park DJ; Jang HC; Park YJ
    Clin Endocrinol (Oxf); 2014 May; 80(5):735-42. PubMed ID: 24117478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
    Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
    Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fine-needle aspiration cytology repetition in thyroid nodules with non-diagnostic findings or atypia of undetermined significance/follicular lesions of undetermined significance: Does time matters?
    Benido Silva V; Borges Duarte D; Teresa Pereira M; Couto de Carvalho A; Freitas C
    Ann Endocrinol (Paris); 2022 Aug; 83(4):232-236. PubMed ID: 35489413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups.
    García Pascual L; Surralles ML; Morlius X; Garcia Cano L; González Mínguez C
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):577-583. PubMed ID: 30262240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.
    Topaloglu O; Baser H; Cuhaci FN; Sungu N; Yalcin A; Ersoy R; Cakir B
    Endocrine; 2016 Oct; 54(1):156-168. PubMed ID: 27172917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atypia of undetermined significance in thyroid fine-needle aspiration cytology: prediction of malignancy by US and comparison of methods for further management.
    Lee KH; Shin JH; Oh YL; Hahn SY
    Ann Surg Oncol; 2014 Jul; 21(7):2326-31. PubMed ID: 24566858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histologic outcome of thyroid nodules with repeated diagnosis of atypia in thyroid fine-needle aspiration biopsy.
    Selek A; Cetinarslan B; Kıvrakoğlu E; Karadağ DT; Tarkun I; Canturk Z; Akyay OZ
    Future Oncol; 2016 Mar; 12(6):801-5. PubMed ID: 26838590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyroid cancer detection rate and associated risk factors in patients with thyroid nodules classified as Bethesda category III.
    Mileva M; Stoilovska B; Jovanovska A; Ugrinska A; Petrushevska G; Kostadinova-Kunovska S; Miladinova D; Majstorov V
    Radiol Oncol; 2018 Sep; 52(4):370-376. PubMed ID: 30265655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to thyroid Bethesda system.
    Ustün H; Astarcı HM; Altunkaya C; Yılmaz S; Barın A; Ekici S; Caydere M
    Acta Cytol; 2012; 56(4):361-9. PubMed ID: 22846585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
    Desai D; Lepe M; Baloch ZW; Mandel SJ
    Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytologic subclassification of atypia of undetermined significance may predict thyroid nodules more likely to be malignant at surgery.
    Shrestha RT; Hennessey JV
    Diagn Cytopathol; 2016 Jun; 44(6):492-8. PubMed ID: 27028482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atypia of undetermined significance and follicular lesions of undetermined significance: sonographic assessment for prediction of the final diagnosis.
    Kamaya A; Lewis GH; Liu Y; Akatsu H; Kong C; Desser TS
    J Ultrasound Med; 2015 May; 34(5):767-74. PubMed ID: 25911708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
    Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
    Kiernan CM; Solórzano CC
    J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Testing Has Limited Utility in the Surgical Evaluation of Bethesda III Thyroid Nodules.
    Scola WH; Linhares SM; Handelsman RS; Picado O; Khan ZF; Farrá JC; Lew JI
    J Surg Res; 2021 Dec; 268():209-213. PubMed ID: 34358733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malignancy rate of thyroid nodules defined as follicular lesion of undetermined significance and atypia of undetermined significance in thyroid cytopathology and its relation with ultrasonographic features.
    Çuhaci N; Arpaci D; Üçler R; Yazgan AK; Kıyak G; Yalçin S; Ersoy PE; Güler G; Ersoy R; Çakir B
    Endocr Pathol; 2014 Sep; 25(3):248-56. PubMed ID: 24532158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.